[go: up one dir, main page]

KR830009058A - Method for preparing phenyl substituted pyrido [1,4] benzodiazepines - Google Patents

Method for preparing phenyl substituted pyrido [1,4] benzodiazepines Download PDF

Info

Publication number
KR830009058A
KR830009058A KR1019820000420A KR820000420A KR830009058A KR 830009058 A KR830009058 A KR 830009058A KR 1019820000420 A KR1019820000420 A KR 1019820000420A KR 820000420 A KR820000420 A KR 820000420A KR 830009058 A KR830009058 A KR 830009058A
Authority
KR
South Korea
Prior art keywords
formula
lower alkyl
compound
halo
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019820000420A
Other languages
Korean (ko)
Other versions
KR890000764B1 (en
Inventor
로이 테일러 2세 챈들러
Original Assignee
알.피.울프
에이 에이취 로빈스 캄파니 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알.피.울프, 에이 에이취 로빈스 캄파니 인코포레이티드 filed Critical 알.피.울프
Publication of KR830009058A publication Critical patent/KR830009058A/en
Application granted granted Critical
Publication of KR890000764B1 publication Critical patent/KR890000764B1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음No content

Description

페닐 치환된 피리도[1,4]벤조디아제핀의 제조방법Method for preparing phenyl substituted pyrido [1,4] benzodiazepines

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (5)

다음 일반식(IV)의 할로-아미노피리딘 및 다음 일반식(III)의 (아미노페닐)아릴메타논의 혼합물을 17 내지 200℃에서 피리도벤조디아제핀으로 폐환시키는데 요하는 시간보다 짧은 시간동안 가열한 다음 생성된 [2-(아미노피리디닐)아미노페닐]아릴메타논을 용매를 사용하여 출발물질 및 약간의 폐환된 피리도벤조디아제핀으로부터 분리시킴을 특징으로 하는 다음 일반식(II)의 [2-[(아미노피리디닐)아미노페닐]아릴메타논의 제조방법.Then a mixture of halo-aminopyridine of formula (IV) and (aminophenyl) arylmethanone of formula (III) is heated at 17-200 ° C. for a time shorter than the time required for ring closure to pyridobenzodiazepine and then produced. [2- (aminopyridinyl) aminophenyl] arylmethanone, separated from the starting materials and some of the ring-closed pyridobenzodiazepines, using a solvent, wherein [2-[(amino Process for the preparation of pyridinyl) aminophenyl] arylmethanone. 상기 일반식에서, Ar은 2,3 또는 4-피리디닐, 2 또는 3의 티에닐, 페닐 또는 할로, 저급알킬, 저급알콕시, 트리플루오로메틸 또는 니트로에서 선택된 1 내지 3의 래디칼에 의해 치환된 페닐이고 같거나 다를 수 있으며, Z는 수소, 할로겐, 저급알킬, 저급알콕시, 히드록시 또는 니트로이고, Y는 수소 또는 저급알킬, 저급알콕시 또는 히드록시에서 선택된 1 내지 2의 래디칼이고 같거나 다를 수 있다.Wherein Ar is phenyl substituted by 2,3 or 4-pyridinyl, 2 or 3 thienyl, phenyl or 1 to 3 radicals selected from halo, lower alkyl, lower alkoxy, trifluoromethyl or nitro And may be the same or different, Z is hydrogen, halogen, lower alkyl, lower alkoxy, hydroxy or nitro, Y is hydrogen or lower radical of 1 to 2 selected from lower alkyl, lower alkoxy or hydroxy and may be the same or different . 다음 일반식(IV)의 할로-아민피리딘 및 다음 일반식(III)의 (아미노페닐)아릴메타논의 혼합물 또는 다음 일반식(II)인 이의 반응생성물을 반응에서 물이 제거되는데 요하는 시간 및 조건하에 가열하여 폐환시켜 다음 일반식(Ia)의 피리도[1,4]벤조디아제핀을 수득하고 상기에서 제조된 화합물을 나트륨보로시아노히드린으로 환원시켜 다음 일반식(Ia-1)의 화합물을 수득함을 특징으로 하는 다음 일반식(I)의 피리도[1,4]벤조디아제핀의 제조방법.The time and conditions required for the water to be removed from the reaction of a mixture of halo-aminepyridine of formula (IV) and (aminophenyl) arylmethanone of formula (III) or of formula (II) Under heating to ring to obtain the pyrido [1,4] benzodiazepine of the general formula (Ia), and to reduce the compound prepared above by sodium borocyanohydrin to yield the compound of the general formula (Ia-1) A process for the preparation of pyrido [1,4] benzodiazepines of the following general formula (I), which is obtained. 상기 일반식에서, Ar은 2,3, 또는 4-피리디닐, 2 또는 3의 티에닐, 페닐 또는 할로, 저급알킬, 저급알콕시, 트리플루오로메틸 또는 니트로에서 선택된 1 내지 3의 래디칼에 의해 치환된 페닐이고 같거나 다를 수 있으며, Z는 수소, 할로겐, 저급알킬, 저급알콕시, 히드록시 또는 니트로이고, Y는 수소 또는 저급알킬, 저급알콕시 또는 히드록시에서 선택된 1 내지 2의 래디칼이고 같거나 다를 수 있다.Wherein Ar is substituted by 1, 3 radicals selected from 2,3, or 4-pyridinyl, 2 or 3 thienyl, phenyl or halo, lower alkyl, lower alkoxy, trifluoromethyl or nitro Phenyl and may be the same or different, Z is hydrogen, halogen, lower alkyl, lower alkoxy, hydroxy or nitro, Y is hydrogen or lower radical of 1 to 2 selected from lower alkyl, lower alkoxy or hydroxy and may be the same or different have. 제2항에 있어서, 온도가 170 내지 200℃인 방법.The method of claim 2 wherein the temperature is 170 to 200 ° C. 4. 제2항에 있어서, 물을 비양자성 용매중에 환류하에 제거시키는 방법.The method of claim 2 wherein the water is removed under reflux in an aprotic solvent. 1) 다음 일반식(IV)의 할로-아미노피리딘 및 다음 일반식(III)의 (아미노페닐)아릴메타논의 혼합물 또는 다음 일반식(II)인 이의 반응생성물을 반응에서 물이 제거되는데 요하는 시간 및 조건하에 가열하여 폐환시켜 다음 일반식(Ia)의 피리도[1,4]벤조디아제핀을 수득하고1) the time required for water to be removed from the reaction of a mixture of halo-aminopyridine of formula (IV) and (aminophenyl) arylmethanone of formula (III), or a reaction product thereof of formula (II): And ring-closed under heating to obtain pyrido [1,4] benzodiazepine of the general formula (Ia), 2) 임의로, 1)단계에서 제조된 화합물을 나트륨보로시아노히드린으로 환원시켜 다음 일반식(Ia-1)의 화합물을 수득하고2) optionally, reducing the compound prepared in step 1) with sodium borocyanohydrin to obtain the compound of formula (Ia-1) 3) 1)단계 또는 2)단계의 생성물을 할로-Alk'Q시약(여기에서 Q는 -N-(저급알킬)2, 1-피롤리디닐 1-피페리디닐, 4-치환-피페라진-1-일, 4-모르폴리노, 1-프탈이미도,저급알킬 또는 할로임)과 반응시키고 n이 0인 경우, 임의로 나트륨보로시아노히드린으로 환원시켜 다음 일반식(Ib)를 갖는 혼합물에서 선택되는 화합물을 수득하고3) The product of step 1) or 2) is subjected to halo-Alk'Q reagent, wherein Q is -N- (lower alkyl) 2 , 1-pyrrolidinyl 1-piperidinyl, 4-substituted-piperazine- 1-day, 4-morpholino, 1-phthalimido, Lower alkyl or halo) and, if n is 0, optionally reduced to sodium borocyanohydrin to give a compound selected from the mixture having the following general formula (lb) 4) Q가 프탈이미도인 경우, 알콜성 히드라진 하이드레이트 및 산과 반응시키고, n이 0인 경우, 임의로 나트륨보로시아노히드린으로 환원시켜 다음 일반식(Ic)의 화합물을 수득하고4) When Q is phthalimido, it is reacted with alcoholic hydrazine hydrate and acid, and when n is 0, it is optionally reduced with sodium borocyanohydrin to give the compound of formula (Ic) 5) 임의로 4)단계에서 제조된 화합물을 트리에틸오르토포르메이트와 다음 일반식(Id)의 메탄이미드성 에스테르를 형성하기에 충분한 시간동안 반응시킨 후 메탄이미드성 에스테르를 수소화붕소나트륨으로 환원시키고, n이 0인 경우 나트륨보로시아노히드린으로 환원시켜 다음 일반식(Ie)의 화합물을 수득하고5) optionally reacting the compound prepared in step 4) with triethylorthoformate for a time sufficient to form the methaneimide ester of formula (Id) and then reducing the methaneimide ester with sodium borohydride. When n is 0, it is reduced to sodium borocyanohydrin to give a compound of formula (Ie) 6) 임의로, 4)단계에서 제조된 화합물을 에틸클로로포르메이트(및 트리에틸아민)와 반응시키고 이어서 수소화리튬알미늄으로 환원시켜 다음 일반식(Ie-1)의 화합물을 수득하고6) optionally, reacting the compound prepared in step 4) with ethylchloroformate (and triethylamine) followed by reduction with lithium aluminum hydride to obtain the compound of formula (Ie-1) 7) 임의로 3)단계에서 제조된 화합물(여기에서 Q는저급알킬임)을 가수분해하여 다음 일반식(Ie-2)의 화합물을 수득하고7) optionally a compound prepared in step 3) wherein Q is Hydrolyzing to lower alkyl to give the compound of formula (Ie-2) 8) 이와 달리, 3)단계에서 제조된 화합물에서 Q가 클로로인 경우, 디알킬아민과 반응시켜 다음 일반식 (Ib-3)의 화합물을 수득함을 특징으로 하는 다음 일반식(I)의 피리도[1,4]벤조디아제핀 및 이의 산부가염의 제조방법.8) In contrast, when Q is chloro in the compound prepared in step 3), the pyri of formula (I) is characterized in that it is reacted with dialkylamine to give a compound of formula (Ib-3) [1,4] Benzodiazepine and a method for preparing acid addition salt thereof. 상기 일반식에서, R은 수소, 저급알킬, -Alk'-NR1R2또는 Alk'-N=CH-OC2H5이고, R1및 R2는 수소, 저급알킬 또는 -C(O)-O-저급알킬이거나 또는 R1및 R2는 인접한 질소원자와 함께 1-프탈이미도, 1-피롤리디닐, 4-모르폴리노, 1-피페라지노, 또는 4-치환된 피페라진-1-일이고, Ar은 2,3 또는 4-피리디닐, 2 또는 3-티에닐, 페닐 또는 할로, 저급알킬, 저급알콕시, 트리플루오로메틸 또는 니트로에서 선택된 1 내지 3의 래디칼에 의해 치환된 페닐이고 같거나 다를 수 있으며, Alk'은 탄소수 1 내지 8의 직쇄 또는 측쇄탄화수소이고, Z는 수소, 할로겐, 저급알킬, 저급알콕시, 히드록시 또는 니트로이고, Y는 수소 또는 저급알킬, 저급알콕시 또는 하이드록시에서 선택된 1 내지 2의 래디칼이고 같거나 다를 수 있으며, n은 0 및 1 이고, n이 0인 경우 점선은 이중결합이다.Wherein R is hydrogen, lower alkyl, -Alk'-NR 1 R 2 or Alk'-N = CH-OC 2 H 5 , and R 1 and R 2 are hydrogen, lower alkyl or -C (O)- Is O-lower alkyl or R 1 and R 2 together with adjacent nitrogen atoms are 1-phthalimido, 1-pyrrolidinyl, 4-morpholino, 1-piperazino, or 4-substituted piperazine-1 -Is yl, Ar is phenyl substituted by 1 to 3 radicals selected from 2,3 or 4-pyridinyl, 2 or 3-thienyl, phenyl or halo, lower alkyl, lower alkoxy, trifluoromethyl or nitro And may be the same or different, Alk 'is a straight or branched chain hydrocarbon having 1 to 8 carbon atoms, Z is hydrogen, halogen, lower alkyl, lower alkoxy, hydroxy or nitro, Y is hydrogen or lower alkyl, lower alkoxy or hydroxy 1 to 2 radicals selected from Roxy and may be the same or different, where n is 0 and 1, and when n is 0 the dotted line is a double bond. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR8200420A 1981-09-24 1982-02-02 Phenyl substituted pyrido [1,4] benzodiazepines and methods for preparing the same Expired KR890000764B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30508081A 1981-09-24 1981-09-24
US305,080 1981-09-24
US305080 1981-09-24

Publications (2)

Publication Number Publication Date
KR830009058A true KR830009058A (en) 1983-12-17
KR890000764B1 KR890000764B1 (en) 1989-04-05

Family

ID=23179241

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8200420A Expired KR890000764B1 (en) 1981-09-24 1982-02-02 Phenyl substituted pyrido [1,4] benzodiazepines and methods for preparing the same

Country Status (27)

Country Link
JP (1) JPS5865290A (en)
KR (1) KR890000764B1 (en)
BE (1) BE891666A (en)
CA (1) CA1199324A (en)
CH (1) CH651833A5 (en)
DE (1) DE3150522A1 (en)
DK (3) DK186282A (en)
EG (1) EG15904A (en)
ES (6) ES8303348A1 (en)
FI (1) FI71935C (en)
FR (1) FR2515183B1 (en)
GR (1) GR78473B (en)
HU (2) HU189426B (en)
IE (1) IE52493B1 (en)
IL (1) IL64284A (en)
IN (1) IN156080B (en)
IT (1) IT1146728B (en)
LU (1) LU83865A1 (en)
NL (1) NL8200549A (en)
NO (1) NO157700C (en)
NZ (1) NZ198999A (en)
PH (2) PH17847A (en)
PL (6) PL143597B1 (en)
PT (1) PT74286B (en)
SE (2) SE448629B (en)
YU (1) YU46128B (en)
ZA (1) ZA817866B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825549A (en) * 1972-10-24 1974-07-23 Squibb & Sons Inc Certain dihydropyrido(2,1-b)(1,3)benzodi-azepines and benzodiazocines
DE2424811C3 (en) * 1974-05-22 1981-08-20 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrido-benzodiazepinones, process for their preparation and medicaments containing them
SE422799B (en) * 1975-05-28 1982-03-29 Merck & Co Inc ANALOGY PROCEDURE FOR PREPARATION OF 1,3-DIHYDROIMIDAZO (4,5-B) PYRIDIN-2-ONER

Also Published As

Publication number Publication date
FI813976L (en) 1983-03-25
SE8600688D0 (en) 1986-02-17
ES8604531A1 (en) 1986-02-01
FR2515183B1 (en) 1986-11-14
ES507971A0 (en) 1983-02-01
PL138859B1 (en) 1986-11-29
PL234426A1 (en) 1984-01-02
ES8402295A1 (en) 1984-01-16
IT8168605A0 (en) 1981-12-09
SE8106573L (en) 1983-03-25
IL64284A0 (en) 1982-02-28
FI71935C (en) 1987-03-09
PL241409A1 (en) 1984-05-21
IN156080B (en) 1985-05-11
SE8600688L (en) 1986-02-17
DK403387D0 (en) 1987-08-03
IE52493B1 (en) 1987-11-25
YU62582A (en) 1986-04-30
PT74286A (en) 1982-02-01
FI71935B (en) 1986-11-28
SE455305B (en) 1988-07-04
ES8607726A1 (en) 1986-06-01
DK186282A (en) 1983-03-25
ES543328A0 (en) 1986-06-01
CA1199324A (en) 1986-01-14
YU46128B (en) 1993-05-28
PL143322B1 (en) 1988-02-29
HU189426B (en) 1986-07-28
ES8504148A1 (en) 1985-04-01
SE448629B (en) 1987-03-09
DK403487A (en) 1987-08-03
BE891666A (en) 1982-04-16
DE3150522A1 (en) 1983-04-07
HU187393B (en) 1985-12-28
IT1146728B (en) 1986-11-19
JPS5865290A (en) 1983-04-18
PH17847A (en) 1985-01-09
ES526562A0 (en) 1985-04-01
ES516051A0 (en) 1983-09-16
NO157700C (en) 1988-05-04
FR2515183A1 (en) 1983-04-29
EG15904A (en) 1987-03-30
PL137068B1 (en) 1986-04-30
DK403487D0 (en) 1987-08-03
NO813839L (en) 1983-03-25
GR78473B (en) 1984-09-27
PL241410A1 (en) 1984-01-02
ES516052A0 (en) 1984-01-16
PL143596B1 (en) 1988-02-29
LU83865A1 (en) 1983-09-02
ES526563A0 (en) 1986-02-01
IE812769L (en) 1983-03-24
PT74286B (en) 1983-06-27
PH20536A (en) 1987-02-09
PL143597B1 (en) 1988-02-29
NL8200549A (en) 1983-04-18
NO157700B (en) 1988-01-25
NZ198999A (en) 1987-07-31
CH651833A5 (en) 1985-10-15
ES8308563A1 (en) 1983-09-16
IL64284A (en) 1986-12-31
ES8303348A1 (en) 1983-02-01
PL139381B1 (en) 1987-01-31
KR890000764B1 (en) 1989-04-05
DK403387A (en) 1987-08-03
ZA817866B (en) 1982-10-27
HUT34732A (en) 1985-04-28

Similar Documents

Publication Publication Date Title
EP0678519B1 (en) Intermediates for the preparation of pyrazoloazole photographic couplers, processes of making and using them
KR850002483A (en) Method for preparing 1-heteroaryl-4-[(2,5-pyrrolidindione-1-yl] piperazine derivative
FI62668C (en) FOERFARANDE FOER FRAMSTAELLNING AV H1- OCH H2-HISTAMINANTAGONISTISKA 2-AMINO-4-PYRIMIDONDERIVAT
US4332809A (en) Pyridinecarboxamide derivatives and process for the preparation thereof
KR840000508A (en) Method for preparing 4-anilinopyrimidine derivative
JPS6041677A (en) Pyrimido(6,1-a)isoquinolin-2,4-dione derivative and manufacture
Lee et al. Concise total syntheses of paullone and kenpaullone via cyanide-catalyzed intramolecular imino-stetter reaction
Geisler et al. Synthesis of 1, 3-selenazoles and bis (selenazoles) from primary selenocarboxylic amides and selenourea
IE48080B1 (en) 2-nitro aminopyrimidone derivatives,a process for their preparation and their use to prepare 2-aminopyrimidone derivatives which have histamine h2-antagonist activity
Dumitraşcu et al. Steric effects on the sydnones reactivity. New sydnones and pyrazoles
KR830009058A (en) Method for preparing phenyl substituted pyrido [1,4] benzodiazepines
Alberola et al. Synthesis of [1] benzopyrano [4, 3-b] pyrrol-4 (1H)-ones from 4-chloro-3-formylcoumarin
US4113954A (en) Process for the preparation of 3-anilino-5-pyrazolones
US4864032A (en) Process for the preparation of indazoles
Dyachenko et al. 3-Amino-3-thioxopropanamide in the Synthesis of Functionally Substituted Nicotinamides.
CA1187880A (en) Process for the preparation of 5,6,7,7a, tetrahydro- 4h-thieno [3,2-c] pyridin-2-ones
US3419563A (en) Process for producing 7-amino-carbostyrile derivatives
Geisler et al. Synthesis and functionalization of 4-halomethyl-1, 3-selenazoles
US3960926A (en) Process for preparing azasulfonium halide salts
US5055587A (en) Process for preparing 1H-pyrazolo-[5,1-c]-1,2,4-triazole compounds
KR930009994A (en) Urea fusion method to synthesize 3-phenoxy-1-azetidinecarboxamide
KR840002837A (en) Method for preparing pyrido [1,4] benzodiazepines
US3954797A (en) Process for preparing azasulfonium halide salts
Helmholz et al. Synthesis of Unsymmetrical Pyrrolo [3, 2-b] pyrrole-2, 5-diones and Bis (quinazolin-4-on-2-yls) by Double-Anion-Capture Reactions of Unsymmetrical Oxaldi (arylimidoyl) Dichlorides
GB1596376A (en) 4,5-disubstituted imidazole-2-thiones processes for their preparation and their use as intermediates

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19920406

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19920406